Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia

Investig Clin Urol. 2016 Nov;57(6):431-436. doi: 10.4111/icu.2016.57.6.431. Epub 2016 Oct 24.

Abstract

Purpose: To investigate the change in urinary urgency and predictors of urgency improvement after holmium laser enucleation of the prostate (HoLEP) in men with benign prostatic hyperplasia (BPH).

Materials and methods: We retrospectively analyzed the medical records of patients who were treated with HoLEP for BPH and had preoperative urgency measuring ≥3 on a 5-point urinary sensation scale. Those with prostate cancer diagnosed prior to or after HoLEP, a history of other prostatic and/or urethral surgery, moderate to severe postoperative complications, and neurogenic causes were excluded. Patients who had improved urgency with antimuscarinic medication after HoLEP were excluded. We divided the patients into 2 groups based on urgency symptoms 3 months after HoLEP: improved and unimproved urgency. Improved urgency was defined as a reduction of 2 or more points on the 5-point urinary sensation scale. Preoperative clinical and urodynamic factors as well as perioperative factors were compared between groups.

Results: In total, 139 patients were included in this study. Voiding parameters in all patients improved significantly after HoLEP. Seventy-one patients (51.1%) had improved urgency, while 68 (48.9%) did not show any improvement. A history of acute urinary retention (AUR) and postvoid residual were associated with postoperative urgency improvement in univariate analysis. In multivariate analysis, a history of AUR was an independent factor affecting urgency improvement.

Conclusions: A preoperative history of AUR could influence the change in urgency after HoLEP surgery in patients with BPH.

Keywords: Holmium; Laser therapy; Overactive urinary bladder; Prostatic hyperplasia.

Publication types

  • Evaluation Study
  • Multicenter Study

MeSH terms

  • Aged
  • Holmium
  • Humans
  • Lasers, Solid-State / therapeutic use*
  • Male
  • Middle Aged
  • Prognosis
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / pathology
  • Prostatic Hyperplasia / physiopathology
  • Prostatic Hyperplasia / surgery*
  • Psychometrics
  • Quality of Life
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Urinary Bladder, Overactive / etiology
  • Urinary Bladder, Overactive / physiopathology
  • Urinary Bladder, Overactive / surgery*
  • Urinary Retention / etiology
  • Urinary Retention / surgery
  • Urodynamics

Substances

  • Holmium